Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Misuse of Antibiotics May Spur Bacterial Acquisition of Drug Resistance

By BiotechDaily International staff writers
Posted on 18 Mar 2013
Petri dish with bacterial colonies growing in a hazardous substrate (Photo courtesy of Dr. Mohammed Bakkali, Department of Genetics, University of Granada).
Petri dish with bacterial colonies growing in a hazardous substrate (Photo courtesy of Dr. Mohammed Bakkali, Department of Genetics, University of Granada).
A recent paper reviewed the scientific literature regarding acquisition of drug resistance by bacteria and advanced the theory that in most cases resistance is transferred by uptake of DNA that had been released by resistant organisms that had been broken open by the stress of antibiotic treatment.

The author, Dr. Mohammed Bakkali, professor of genetics at the University of Granada (Spain) reviewed some of the literature on bacterial acquisition of drug resistance and discussed four hypotheses on how and why bacteria take up DNA. He argued in the February 5, 2013, online edition of the journal Archives of Microbiology that DNA uptake by bacteria is an accidental by-product of bacterial adhesion and twitching motility. Adhesion and motility are generally increased in stressful conditions, which may explain why bacteria increase DNA uptake in these conditions.

This hypothesis has significant clinical implications and finds further support from the fact that antibiotics sometimes fail to eliminate the targeted bacterium while inevitably causing stress to others. The widespread misuse of antibiotics may thus not only be selecting for resistant strains, but may also be causing bacteria to take up more DNA with the consequent increase in the chances of acquiring drug resistance and virulence.

"Our current indiscriminate use of antibiotics not only selects the resistant bacteria, but also means that the bacteria take up more DNA, due to their increased motility in response to the stress that the antibiotic subjects them to," said Dr. Bakkali. "In this way, the nonresistant bacteria become resistant completely by accident on ingesting this DNA and can even become much more virulent, partly due to the stress we subject them to when we make an abusive use of antibiotics."

Related Links:

University of Granada



Channels

Genomics/Proteomics

view channel
Image: In mice, mitochondria (green) in healthy (left) and Mfn1-deficient heart muscle cells (center) are organized in a linear arrangement, but the organelles are enlarged and disorganized in Mfn2-deficient cells (right) (Photo courtesy of the Rockefeller Press).

Cell Biologists Find That Certain Mitochondrial Diseases Stem from Coenzyme Q10 Depletion

A team of German cell biologists has linked the development of certain mitochondrial-linked diseases to depletion of the organelles' pool of coenzyme Q10 brought about by mutation in the MFN2 gene, which... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Lab Technologies

view channel
Image: The FLUOVIEW FVMPE-RS Gantry microscope (Photo courtesy of Olympus).

New Multiphoton Laser Scanning Microscope Configurations Expand Research Potential

Two new configurations of a state-of-the-art multiphoton laser scanning microscope extend the usefulness of the instrument for examining rapidly occurring biological events and for obtaining images from... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.